Loading...
Loading...
Contributors:
Dataset URI:
10.3389/fmed.2026.1879397.s003ObjectiveTo evaluate the prognostic value of the Prognostic Nutritional Index (PNI) in patients with infectious diseases, focusing on tuberculosis, pneumonia, and sepsis. By synthesizing extant evidence, we examine the association between baseline PNI and clinical outcomes to inform early risk stratification and nutritional monitoring. Additionally, we probe underlying pathophysiological mechanisms, offering prognostic insights.MethodsA systematic literature search was conducted across five databases, including PubMed, Web of Science, Embase, the Cochrane Library, and China National Knowledge Infrastructure (CNKI), from inception to June 2026. Following methodological appraisal via the Newcastle-Ottawa Scale, we investigated associations between PNI and mortality or unfavorable outcomes. PNI was uniformly calculated at baseline using the formula: PNI = serum albumin (g/L) + 5 × lymphocyte count (×109/L). Meta-analysis, Egger's test, and sensitivity analysis were performed in R software (version 4.5.0).ResultsFrom an initial pool of 1,383 relevant studies, 10 studies comprising 28,757 patients were included in the final analysis. Disease-stratified meta-analysis underscores PNI's prognostic association in infectious diseases. Notably, among sepsis patients, elevated baseline PNI is associated with a significantly attenuated mortality risk (hazard ratio [HR]: 0.63; 95% confidence interval [CI]: 0.44, 0.90). Similarly, in the pneumonia subgroup, a high PNI demonstrated a significant inverse association with mortality (HR: 0.47; 95% CI: 0.30, 0.73). Conversely, in the tuberculosis subgroup, the association between PNI and mortality did not reach statistical significance (HR: 0.38; 95% CI: 0.04, 3.82). Overall, higher PNI remained a significant protective factor against mortality or unfavorable clinical outcomes (pooled HR: 0.52; 95% CI: 0.39, 0.71; P ConclusionsReduced baseline PNI correlates with heightened mortality in sepsis and pneumonia, yet its prognostic value in tuberculosis remains uncertain. Although PNI is a cost-effective clinical adjunct, the current evidence is too heterogeneous to support its universal use in infectious diseases. Addressing these gaps requires large-scale prospective investigations across a wider spectrum of diseases.
Keyword(s):
Foetal Development and Medicine; infectious diseases; meta-analysis; PNI; prognosis.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)